Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance.
Tefferi A, Abdelmagid M, Loscocco GG, Fathima S, Begna KH, Al-Kali A, Foran J, Palmer J, Badar T, Patnaik MM, Reichard KK, He R, Zepeda Mendoza CJ, Shah M, Orazi A, Arber DA, Pardanani A, Vannucchi AM, Hiwase D, Gangat N, Guglielmelli P. Tefferi A, et al. Among authors: patnaik mm. Am J Hematol. 2025 Jan 28. doi: 10.1002/ajh.27609. Online ahead of print. Am J Hematol. 2025. PMID: 39873146
Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia.
Tessier S, McCullough KB, Gangat N, Begna KH, Saliba AN, Mangoankar AA, Shah MV, Hogan WJ, Patnaik MM, Al-Kali A, Alkhateeb HB. Tessier S, et al. Among authors: patnaik mm. Leuk Lymphoma. 2025 Jan 16:1-5. doi: 10.1080/10428194.2024.2443017. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39817316 No abstract available.
A mutant ASXL1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia.
Dong Z, Sepulveda H, Arteaga-Vazquez LJ, Blouin C, Fernandez J, Binder M, Chou WC, Tien HF, Patnaik M, Faulkner GJ, Myers SA, Rao A. Dong Z, et al. Among authors: patnaik m. bioRxiv [Preprint]. 2025 Jan 2:2024.01.30.578015. doi: 10.1101/2024.01.30.578015. bioRxiv. 2025. Update in: Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2413302121. doi: 10.1073/pnas.2413302121. PMID: 39803572 Free PMC article. Updated. Preprint.
A mutant ASXL1-BAP1-EHMT complex contributes to heterochromatin dysfunction in clonal hematopoiesis and chronic monomyelocytic leukemia.
Dong Z, Sepulveda H, Arteaga-Vazquez LJ, Blouin C, Fernandez J, Binder M, Chou WC, Tien HF, Patnaik MM, Faulkner GJ, Myers SA, Rao A. Dong Z, et al. Among authors: patnaik mm. Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2413302121. doi: 10.1073/pnas.2413302121. Epub 2025 Jan 3. Proc Natl Acad Sci U S A. 2025. PMID: 39752521
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
Gangat N, Elbeih A, Ghosoun N, McCullough K, Aperna F, Johnson IM, Abdelmagid M, Al-Kali A, Alkhateeb HB, Begna KH, Elliott M, Mangaonkar A, Matin A, Saliba AN, Hefazi Torghabeh M, Litzow MR, Hogan W, Shah M, Patnaik MM, Pardanani A, Badar T, Murthy H, Foran J, Palmer J, Sproat L, Khera N, Arana Yi C, Yates S, Sneider A, Dworkin E, Patel AA, Bazinet A, Senapati J, Bataller A, DiNardo C, Kadia T, Tefferi A. Gangat N, et al. Among authors: patnaik mm. Am J Hematol. 2025 Feb;100(2):260-271. doi: 10.1002/ajh.27564. Epub 2024 Dec 13. Am J Hematol. 2025. PMID: 39671248 Free PMC article.
A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis.
Haque T, Shastri A, Desai P, Xie Z, Hammond D, King Z, Kishtagari A, Madanat YF, Abaza Y, Silver AJ, Singh A, Borate UM, Heimlich JB, Slosky DA, Bolton KL, Patnaik MS, Bick AG, Verma AK, Jaiswal S, Steensma DP, Savona MR. Haque T, et al. Among authors: patnaik ms. Br J Haematol. 2024 Dec 9. doi: 10.1111/bjh.19925. Online ahead of print. Br J Haematol. 2024. PMID: 39653653 Review.
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response.
Mohammed Ismail W, Fernandez JA, Binder M, Lasho TL, Kim M, Geyer SM, Mazzone A, Finke CM, Mangaonkar AA, Lee JH, Wang L, Kim KH, Simon VA, Rakhshan Rohakthar F, Munankarmy A, Byeon SK, Schwager SM, Harrington JJ, Snyder MR, Robertson KD, Pandey A, Wieben ED, Chia N, Gaspar-Maia A, Patnaik MM. Mohammed Ismail W, et al. Among authors: patnaik mm. Blood Adv. 2025 Jan 28;9(2):402-416. doi: 10.1182/bloodadvances.2024014467. Blood Adv. 2025. PMID: 39631069
577 results